{
    "2021-07-12": [
        [
            {
                "time": "",
                "original_text": "欧普康视：去年年报已经披露的医院都是并表的，目前医院总体上是亏损的，但每家医院都在逐年好转",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "医院",
                        "亏损",
                        "逐年好转"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "欧普康视：阿托品滴眼液目前正在进行院内制剂中试后的检测和试验，完成后可以申请院内制剂注册，具体时长不便预测",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "阿托品滴眼液",
                        "检测",
                        "试验",
                        "注册"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：十四五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "十四五",
                        "血制品",
                        "成长周期",
                        "天坛生物",
                        "博雅生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}